An Italian case of nasopharyngeal carcinoma was studied clinically; the immunologic study showed the correlation with the Epstein-Barr virus specific antigen.
Get full access to this article
View all access options for this article.
References
1.
BergeG., BrunA., HakanssonC. H., LindgrenM., NordberguB.: Sensitivity to irradiation of the brain stem. Irradiation myelitis in the treatment of nasopharynx carcinoma. Cancer, 33: 1263–1268, 1974.
2.
De SchryverA., KleinG., HenleW., HenleG.: EB virus-associated antibodies in Caucasian patients with carcinoma of the nasopharynx and in long-term survivors after treatment. Int. J. Cancer, 13: 319–325, 1974.
3.
De StefaniE., FuzmanP., OreggiaF.: Carcinoma du cavum: revision anatomoclinique de 47 cas. Problème du lymphoépiteliome. Rev. Laryng., 94: 11–12, 1973.
4.
De TheG., GeserA.: Nasopharyngeal carcinoma: recent studies and outlook for a viral etiology. Cancer Res., 34: 1196–1206, 1974.
5.
De TheG., HoJ. H. C., AblascidV.: Nasopharyngeal carcinoma. IX. Antibodies to EBNA and correlation with response to other EBV. Antigens in Chinese patients. Int. J. Cancer, 16: 713–721, 1975.
6.
ErnbergI., MasucciG., KleinG.: Persistence of EBV nuclear antigen (EBNA) in cell entering the EBV viral cycle. Int. J. Cancer, 17: 197–203, 1976.
7.
HendersonB. E.: Nasopharyngeal carcinoma: present status of knowledge. Cancer Res., 34: 1187–1188, 1974.
8.
HendersonB. E., LouieE., BogdanoffE., HenleW., AlenaB., HenleG.: Antibodies to herpes group viruses in patients with nasopharyngeal and other head and neck cancers. Cancer Res., 34: 1207–1210, 1974.
9.
KleinG.: The Epstein-Barr virus. In: The Herpes Viruses. Cap. 16, pp. 521–555, Academic Press Inc., New York, 1973.
10.
KleinG.: Epstein-Barr virus (EBV)-induced transformation of human lymphoid cells and immunosurveillance against lymphoma development. Ann. Immunol. Paris, 124: 391–405, 1973.
11.
WolfH., zur HausenH., BeckerV.: EB viral genomes in epithelial nasopharyngeal carcinoma cells. Nature New Biol., 244: 245–247, 1973.
